Feasibility of Exposure-Response Analyses for Clinical Dose-Ranging Studies of Drug Combinations.
Saved in:
| Title: | Feasibility of Exposure-Response Analyses for Clinical Dose-Ranging Studies of Drug Combinations. |
|---|---|
| Authors: | Papathanasiou T; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. tpap@novonordisk.com.; Novo Nordisk A/S, Quantitative Clinical Pharmacology, Vandtårnsvej 108-110, 2860, Søborg, Denmark. tpap@novonordisk.com., Strathe A; Novo Nordisk A/S, Quantitative Clinical Pharmacology, Vandtårnsvej 108-110, 2860, Søborg, Denmark., Hooker AC; Pharmacometrics Research Group, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden., Lund TM; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Overgaard RV; Novo Nordisk A/S, Quantitative Clinical Pharmacology, Vandtårnsvej 108-110, 2860, Søborg, Denmark. |
| Source: | The AAPS journal [AAPS J] 2018 Apr 23; Vol. 20 (3), pp. 64. Date of Electronic Publication: 2018 Apr 23. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1550-7416 |
|---|---|
| DOI: | 10.1208/s12248-018-0226-5 |
